Date: 2013-03-25
Type of information: Collaboration agreement
Compound:
Company: The University of Nottingham (UK) Fusion IP (UK)
Therapeutic area:
Type agreement: collaboration
Action mechanism:
Disease:
Details: The University of Nottingham has signed an agreement with Fusion IP plc, which will allow the company to invest in the University’s emergent spin-out companies. Fusion IP specialises in commercialising intellectual property arising from university research. The company has just announced that it has raised funding of £20 million through a share issue to new and existing institutional shareholders.
Fusion will receive equity stakes in any spin-out companies it invests in on pre-agreed terms. It will provide business building expertise and mentoring to emergent companies, as well as access to its other co-investment networks. Fusion will also draw on the funds to invest in new spin-out companies from their existing partner universities. This new agreement will be complementary to the University’s Nottingham Angels network which has co-investment rights under the agreement and the £37 million Nottingham Investment Fund which will launch in April of this year.
The University of Nottingham has formed more than 40 spin-out companies and currently has a portfolio of 28 companies, 16 of which have products or services in the market place and which between them have raised over £50 million in external investment in recent years.
Fusion IP already owns the rights to 100% of university-owned research generated at two of the UK\'s leading universities – The University of Sheffield and Cardiff University. These exclusive partnerships enable the company to turn research into valuable businesses through the creation of portfolio of companies.
Financial terms:
Latest news:
